| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers R > Headlines for Resonetics LLC > News item |
Resonetics shops amendment to shift term loan to SOFR pricing
By Sara Rosenberg
New York, April 10 – Resonetics LLC is seeking a negative consent amendment to transition its term loan to SOFR from Libor and added CSA, according to a market source.
The company is offering ARRC CSA of 11.448 basis points one-month rate, 26.161 bps three-month rate and 42.826 bps six-month rate.
Credit Suisse Securities (USA) LLC is the lead on the deal.
The amendment deadline is end of day on Friday, the source added.
Resonetics is a MedTech contract manufacturing organization specializing in micro-manufacturing and other highly technical capabilities.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.